The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
The link between schizophrenia and substance use disorder: A unifying hypothesis
Open accessAbstract
Substance use disorders occur commonly in patients with schizophrenia and dramatically worsen their overall clinical course. While the exact mechanisms contributing to substance use in schizophrenia are not known, a number of theories have been put forward to explain the basis of the co-occurrence of these disorders. We propose here a unifying hypothesis that combines recent evidence from epidemiological and genetic association studies with brain imaging and pre-clinical studies to provide an updated formulation regarding the basis of substance use in patients with schizophrenia. We suggest that the genetic determinants of risk for schizophrenia (especially within neural systems that contribute to the risk for both psychosis and addiction) make patients vulnerable to substance use. Since this vulnerability may arise prior to the appearance of psychotic symptoms, an increased use of substances in adolescence may both enhance the risk for developing a later substance use disorder, and also serve as an additional risk factor for the appearance of psychotic symptoms. Future studies that assess brain circuitry in a prospective longitudinal manner during adolescence prior to the appearance of psychotic symptoms could shed further light on the mechanistic underpinnings of these co-occurring disorders while identifying potential points of intervention for these difficult-to-treat co-occurring disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242 · cited 1×
“The self-medication hypothesis suggests that substance use in patients with schizophrenia is based on the wish to lessen symptoms or decrease side effects of antipsychotic treatment (Khantzian, 1997).”
BackgroundAdverse health effects of marijuana use.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774
Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population
Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K., Isometsä, E., Pirkola, S., Partonen, T., Tuulio-Henriksson, A., Hintikka, J., Kieseppä, T., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.19 · Cited by 1,516
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1107 · Cited by 1,262
Genome-wide meta-analyses identify multiple loci associated with smoking behavior
The Tobacco and Genetics Consortium (2010) · Nature Genetics · doi:10.1038/ng.571 · Cited by 1,098
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw003 · Cited by 899
O'Donnell, P., & Grace, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03622.1995 · Cited by 760
Kendler, K. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110060007 · Cited by 676 · cited 1×
“Epidemiology of substance use and schizophrenia It is clear that lifetime rates of substance use disorders are elevated (above that in the general population) in patients with psychotic disorders (Kendler et al, 1996), including those in their first psychotic episode (Arranz et al, 2015).”
BackgroundCannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
Linszen, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 656
To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test
Lipska, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00137-8 · Cited by 650
Escalation of Drug Use in Early-Onset Cannabis Users vs Co-twin Controls
Lynskey, M. T., Heath, A. C., Bucholz, K. K., Slutske, W. S., Madden, P. A. F., Nelson, E. C., Statham, D. J., & Martin, N. G. (2003) · JAMA · doi:10.1001/jama.289.4.427 · Cited by 649
PKB/AKT: functional insights from genetic models
Scheid, M. P., & Woodgett, J. R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096067 · Cited by 609
Review of Integrated Mental Health and Substance Abuse Treatment for Patients With Dual Disorders
Drake, R. E., Mercer-McFadden, C., Mueser, K. T., McHugo, G. J., & Bond, G. R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033351 · Cited by 596
Prevalence of Substance Abuse in Schizophrenia: Demographic and Clinical Correlates
Mueser, K. T., Yarnold, P. R., Levinson, D. F., Singh, H., Bellack, A. S., Kee, K., Morisson, R. L., & Yadalam, K. G. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.1.31 · Cited by 587
Dysfunction of ventral striatal reward prediction in schizophrenia
Juckel, G., Schlagenhauf, F., Koslowski, M., Wüstenberg, T., Villringer, A., Knutson, B., Wrase, J., & Heinz, A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.07.051 · Cited by 578
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 574
High-potency cannabis and the risk of psychosis
Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.064220 · Cited by 567
Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis
Large, M., Sharma, S., Compton, M. T., Slade, T., & Nielssen, O. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.5 · Cited by 563
A neurobiological basis for substance abuse comorbidity in schizophrenia
Chambers, R. A., Krystal, J. H., & Self, D. W. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01134-9 · Cited by 548
Drug abuse in schizophrenic patients: clinical correlates and reasons for use
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.224 · Cited by 547 · cited 2×
“…from 60–90% for cigarette smoking, as well as 21–86% for alcohol (Volkow, 2009), 17–83% for cannabis (Degenhardt and Hall, 2001; DeQuardo et al., 1994; Dixon et al., 1991; Hambrecht and Hafner, 1996; Karam et al., 2002; Mueser et al., 1995; Perala et al., 2007; Peralta and Cuesta, 1992; Ringen et…”
BackgroundSynaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses
Hartmann, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5887 · Cited by 513
Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground
Weinberger, D. R., & Lipska, B. K. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00013-c · Cited by 470
Cannabis use disorders in the USA: prevalence, correlates and co-morbidity
STINSON, F. S., RUAN, W. J., PICKERING, R., & GRANT, B. F. (2006) · Psychological Medicine · doi:10.1017/s0033291706008361 · Cited by 422
Cannabis dependence and psychotic symptoms in young people
FERGUSSON, D. M., HORWOOD, L. J., & SWAIN-CAMPBELL, N. R. (2003) · Psychological Medicine · doi:10.1017/s0033291702006402 · Cited by 415
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Gage, S. H., Hickman, M., & Zammit, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.001 · Cited by 379
Burstein, M. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1503 · Cited by 365
A Molecular Basis for Nicotine as a Gateway Drug
Kandel, E. R., & Kandel, D. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmsa1405092 · Cited by 353
The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia
Tseng, K. Y., Chambers, R. A., & Lipska, B. K. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.039 · Cited by 341
Substance abuse and the onset of schizophrenia
Hambrecht, M., & Häfner, H. (1996) · Biological Psychiatry · doi:10.1016/s0006-3223(95)00609-5 · Cited by 339
Role of mTOR in physiology and pathology of the nervous system
Swiech, L., Perycz, M., Malik, A., & Jaworski, J. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.015 · Cited by 338
Khan, S. S., Secades-Villa, R., Okuda, M., Wang, S., Pérez-Fuentes, G., Kerridge, B. T., & Blanco, C. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.10.015 · Cited by 293
Ellgren, M., Spano, S. M., & Hurd, Y. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301127 · Cited by 287
Levine, A., Huang, Y., Drisaldi, B., Griffin, E. A., Pollak, D. D., Xu, S., Yin, D., Schaffran, C., Kandel, D. B., & Kandel, E. R. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003062 · Cited by 280
Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
Volkow, N. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp016 · Cited by 273
Abolition of latent inhibition by a single 5 mg dose ofd-amphetamine in man
Gray, N. S., Pickering, A. D., Hemsley, D. R., Dawling, S., & Gray, J. A. (1992) · Psychopharmacology · doi:10.1007/bf02245170 · Cited by 261
Cannabis use and risk of schizophrenia: a Mendelian randomization study
Vaucher, J., Keating, B. J., Lasserre, A. M., Gan, W., Lyall, D. M., Ward, J., Smith, D. J., Pell, J. P., Sattar, N., Paré, G., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.252 · Cited by 260
Hall, L. D. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110050457 · Cited by 257
The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia
Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033464 · Cited by 253
Self-citationDickey, B., & Azeni, H. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.7.973 · Cited by 252
Jones, H. J., Stergiakouli, E., Tansey, K. E., Hubbard, L., Heron, J., Cannon, M., Holmans, P., Lewis, G., Linden, D. E. J., Jones, P. B., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3058 · Cited by 237
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.020 · Cited by 234
Neural correlates of reward processing in schizophrenia — Relationship to apathy and depression
Simon, J. J., Biller, A., Walther, S., Roesch-Ely, D., Stippich, C., Weisbrod, M., & Kaiser, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.11.007 · Cited by 221
Schizophrenia and Co-Occurring Substance Use Disorder
Green, A. I., Drake, R. E., Brunette, M. F., & Noordsy, D. L. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.402 · Cited by 213
Self-citationGage, S. H., Jones, H. J., Burgess, S., Bowden, J., Davey Smith, G., Zammit, S., & Munafò, M. R. (2017) · Psychological Medicine · doi:10.1017/s0033291716003172 · Cited by 211
Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients
Nielsen, M. Ø., Rostrup, E., Wulff, S., Bak, N., Lublin, H., Kapur, S., & Glenthøj, B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.007 · Cited by 210
Cannabis use during adolescent development: Susceptibility to psychiatric illness
Chadwick, B., Miller, M. L., & Hurd, Y. L. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00129 · Cited by 210
Cannabis, Vulnerability, and the Onset of Schizophrenia: An Epidemiological Perspective
Hambrecht, M., & Häfner, H. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00736.x · Cited by 205
Excessive Brain Volume Loss Over Time in Cannabis-Using First-Episode Schizophrenia Patients
Rais, M., Cahn, W., Van Haren, N., Schnack, H., Caspers, E., Hulshoff Pol, H., & Kahn, R. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07071110 · Cited by 202
Reward feedback alterations in unmedicated schizophrenia patients: Relevance for delusions
Schlagenhauf, F., Sterzer, P., Schmack, K., Ballmaier, M., Rapp, M., Wrase, J., Juckel, G., Gallinat, J., & Heinz, A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.016 · Cited by 195
Waltz, J. A., Schweitzer, J. B., Gold, J. M., Kurup, P. K., Ross, T. J., Jo Salmeron, B., Rose, E. J., McClure, S. M., & Stein, E. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.214 · Cited by 186
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models
SPEAR, L. P. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.07.026 · Cited by 185
Nicotine reverses hypofrontality in animal models of addiction and schizophrenia
Koukouli, F., Rooy, M., Tziotis, D., Sailor, K. A., O'Neill, H. C., Levenga, J., Witte, M., Nilges, M., Changeux, J.-P., Hoeffer, C. A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4274 · Cited by 183
A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs
AGRAWAL, A., NEALE, M. C., PRESCOTT, C. A., & KENDLER, K. S. (2004) · Psychological Medicine · doi:10.1017/s0033291704002545 · Cited by 181
Effects of clozapine on smoking in chronic schizophrenic outpatients.
George, T. P., Sernyak, M. J., Ziedonis, D. M., & Woods, S. W. (1995) · PubMed · Cited by 179
Mulder, A. B., Hodenpijl, M. G., & Lopes da Silva, F. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-05095.1998 · Cited by 174
Green, A. I., Zimmet, S. V., Straus, R. D., & Schildkraut, J. J. (1999) · Harvard Review of Psychiatry · doi:10.3109/10673229909017206 · Cited by 173
Self-citationWeiser, M., Reichenberg, A., Grotto, I., Yasvitzky, R., Rabinowitz, J., Lubin, G., Nahon, D., Knobler, H. Y., & Davidson, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1219 · Cited by 171
Gender difference in age at onset of schizophrenia: a meta-analysis
Eranti, S. V., MacCabe, J. H., Bundy, H., & Murray, R. M. (2013) · Psychological Medicine · doi:10.1017/s003329171200089x · Cited by 168
Vetreno, R. P., & Crews, F. T. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00035 · Cited by 166
Zimmet, S. V., Strous, R. D., Burgess, E. S., Kohnstamm, S., & Green, A. I. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00016 · Cited by 163
Self-citationExcessive Brain Volume Loss Over Time in Cannabis-Using First-Episode Schizophrenia Patients
Buckley, P. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79181-3 · Cited by 159
Influence of cannabis abuse on schizophrenic psychopathology
Peralta, V., & Cuesta, M. J. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb01456.x · Cited by 154
Cannabis abuse and risk for psychosis in a prodromal sample
Kristensen, K., & Cadenhead, K. S. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.10.001 · Cited by 148
Schizophrenia: Diathesis-Stress Revisited
Fowles, D. C. (1992) · Annual Review of Psychology · doi:10.1146/annurev.ps.43.020192.001511 · Cited by 148
Brunette, M. F., Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl003 · Cited by 143
Self-citationPsychosis reactivity to cannabis use in daily life: an experience sampling study
Henquet, C., van Os, J., Kuepper, R., Delespaul, P., Smits, M., Campo, J. Á., & Myin‐Germeys, I. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.072249 · Cited by 141
Cannabis and neuroleptic agents in schizophrenia
Knudsen, P., & Vilmar, T. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb02482.x · Cited by 140
Marijuana use in schizophrenia: a clear hazard
Treffert, D. A. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.10.1213 · Cited by 139
Lavín, A., & Grace, A. A. (1994) · Synapse · doi:10.1002/syn.890180205 · Cited by 135
Cannabis use at a young age is associated with psychotic experiences
Schubart, C. D., van Gastel, W. A., Breetvelt, E., Beetz, S. L., Ophoff, R. A., Sommer, I. E., Kahn, R. S., & Boks, M. P. (2010) · Psychological Medicine · doi:10.1017/s003329171000187x · Cited by 128
Real-Time Electronic Ambulatory Monitoring of Substance Use and Symptom Expression in Schizophrenia
Swendsen, J. D., Ben‐Zeev, D., & Granholm, E. L. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030463 · Cited by 126
Kendler, K. S., Lönn, S. L., Sundquist, J., & Sundquist, K. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15010126 · Cited by 121
Esslinger, C., Englisch, S., Inta, D., Rausch, F., Schirmbeck, F. N., Mier, D. U., Kirsch, P., Meyer‐Lindenberg, A., & Zink, M. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.025 · Cited by 120
The role of the phosphatidylinositide 3-kinase–protein kinase B pathway in schizophrenia
Kalkman, H. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.014 · Cited by 116
Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement
Carey, C. E., Arpana Agrawal, A., Bucholz, K. K., Hartz, S. M., Lynskey, M. T., Nelson, E. C., Bierut, L. J., & Bogdan, R. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00149 · Cited by 116
Schlagenhauf, F., Rapp, M. A., Huys, Q. J. M., Beck, A., Wüstenberg, T., Deserno, L., Buchholz, H., Kalbitzer, J., Buchert, R., Bauer, M., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.22000 · Cited by 115
Striatal dopamine release in schizophrenia comorbid with substance dependence
Thompson, J. L., Urban, N., Slifstein, M., Xu, X., Kegeles, L. S., Girgis, R. R., Beckerman, Y., Harkavy‐Friedman, J., Gil, R. B., & Abi‐Dargham, A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.109 · Cited by 115
Expectations and Motives for Substance Use in Schizophrenia
Mueser, K. T., Nishith, P., Tracy, J. I., DeGirolamo, J., & Molinaro, M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.3.367 · Cited by 113
Age at Initiation of Cannabis Use Predicts Age at Onset of Psychosis: The 7- to 8-Year Trend
Stefanis, N. C., Dragović, M., Power, B., Jablensky, A. V., Castle, D. J., & Morgan, V. A. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs188 · Cited by 113
Midbrain activation during pavlovian conditioning and delusional symptoms in schizophrenia
Romaniuk, L., Honey, G. D., King, J. R. L., Whalley, H. C., McIntosh, A. M., Levita, L., Hughes, M., Johnstone, E. C., Day, M., Lawrie, S. M., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.169 · Cited by 113
Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study
Donoghue, K., Doody, G. A., Murray, R. M., Jones, P. B., Morgan, C., Dazzan, P., Hart, J., Mazzoncini, R., & MacCabe, J. H. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2013.12.038 · Cited by 111
Patterns of substance abuse in Schizophrenia: Nature and significance
DeQuardo, J. R., Carpenter, C. F., & Tandon, R. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90010-8 · Cited by 108
AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
the Genetic Risk and Outcome of Psychosis (GROUP) Investigators, van Winkel, R., Genetic Risk and Outcome of Psychosis (GROUP) Investigators, van Beveren, N. J. M., & Simons, C. J. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.141 · Cited by 108
Ira, E., Zanoni, M., Ruggeri, M., Dazzan, P., & Tosato, S. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120178 · Cited by 98
Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder
Ringen, P. A., Lagerberg, T. V., Birkenaes, A. B., Engn, J., Færden, A., Jónsdóttir, H., Nesvåg, R., Friis, S., Opjordsmoen, S., Larsen, F., et al. (2007) · Psychological Medicine · doi:10.1017/s003329170700236x · Cited by 96
Genetic correlation between smoking behaviors and schizophrenia
Hartz, S. M., Horton, A. C., Hancock, D. B., Baker, T. B., Caporaso, N. E., Chen, L., Hokanson, J. E., Lutz, S. M., Marazita, M. L., McNeil, D. W., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.02.022 · Cited by 91
Apud, J. A., & Weinberger, D. R. (2007) · CNS Drugs · doi:10.2165/00023210-200721070-00002 · Cited by 90
Nguyen‐Louie, T. T., Castro, N., Matt, G. E., Squeglia, L. M., Brumback, T., & Tapert, S. F. (2015) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2015.76.738 · Cited by 89
Cannabis and Other Illicit Drugs: Comorbid Use and Abuse/Dependence in Males and Females
Arpana Agrawal, A., Neale, M. C., Prescott, C. A., & Kendler, K. S. (2004) · Behavior Genetics · doi:10.1023/b:bege.0000017868.07829.45 · Cited by 84
Boutros, N., Semenova, S., Liu, W., Crews, F. T., & Markou, A. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu003 · Cited by 84
Salience network-midbrain dysconnectivity and blunted reward signals in schizophrenia
Gradin, V. B., Waiter, G., O'Connor, A., Romaniuk, L., Stickle, C., Matthews, K., Hall, J., & Douglas Steele, J. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.06.003 · Cited by 82 · cited 1×
“Moreover, negative symptoms have been correlated with reduced ventral striatal activity in reward anticipation (Juckel et al., 2006; Simon et al., 2010) and decreased response to reward in both putamen (Waltz et al., 2009) and ventral striatum (Gradin et al., 2013).”
BackgroundEffect of cannabis use on the course of schizophrenia in male patients: A prospective cohort study
van Dijk, D., Koeter, M. W. J., Hijman, R., Kahn, R. S., & van den Brink, W. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.016 · Cited by 82
Abdel‐Baki, A., Ouellet‐Plamondon, C., Salvat, É., Grar, K., & Potvin, S. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.007 · Cited by 82
Simon, J. J., Cordeiro, S. A., Weber, M., Friederich, H., Wolf, R. C., Weisbrod, M., & Kaiser, S. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv067 · Cited by 80
Kivlahan, D. R., Heiman, J. R., Wright, R. C., Jw, M., & Shupe, J. (1991) · Psychiatric Services · doi:10.1176/ps.42.6.609 · Cited by 74
Deserno, L., Wilbertz, T., Reiter, A. M. F., Horstmann, A., Neumann, J., Villringer, A., Heinze, H. –., & Schlagenhauf, F. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.139 · Cited by 71
A Molecular Basis for Nicotine as a Gateway Drug
Kandel, D. B., & Kandel, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1411785 · Cited by 71
Cocaine Abuse in Schizophrenic Patients Treated With Olanzapine Versus Haloperidol
Sayers, S. L., Campbell, E. C., Kondrich, J., Mann, S. C., Cornish, J., O’Brien, C. P., & Caroff, S. N. (2005) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000165089.14736.bf · Cited by 67
Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia
Schwab, S. G., & Wildenauer, D. B. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0450-z · Cited by 66
Salom, C., Betts, K. S., Williams, G. M., Najman, J. M., & Alati, R. (2015) · Addiction · doi:10.1111/add.13058 · Cited by 66
Liu, W., & Crews, F. T. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.014 · Cited by 65
Effect of Patient and Family Insight on Compliance of Schizophrenic Patients
Smith, C. M., Barzman, D. H., & Pristach, C. A. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04773.x · Cited by 63
Brunette, M. F., Dawson, R., O’Keefe, C. D., Narasimhan, M., Noordsy, D. L., Wojcik, J., & Green, A. I. (2011) · Journal of Dual Diagnosis · doi:10.1080/15504263.2011.570118 · Cited by 63
Self-citationFischer, A. S., Whitfield, S., Roth, R. M., Brunette, M. F., & Green, A. I. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.033 · Cited by 62
Self-citationBoehme, R., Deserno, L., Gleich, T., Katthagen, T., Pankow, A., Behr, J., Buchert, R., Roiser, J. P., Heinz, A., & Schlagenhauf, F. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0805-15.2015 · Cited by 61
Berg, S. A., Sentir, A. M., Cooley, B. S., Engleman, E. A., & Chambers, R. A. (2013) · Addiction Biology · doi:10.1111/adb.12082 · Cited by 56
Cariaga-Martínez, A. E., Sáiz-Ruiz, J., & Alelú‐Paz, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00202 · Cited by 53
Chambers, R. A., & Taylor, J. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.019 · Cited by 51
Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome
Green, I. W., & Glausier, J. R. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv136 · Cited by 49
Spoelder, M., Tsutsui, K. T., Lesscher, H. M. B., Vanderschuren, L. J. M. J., & Clark, J. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.139 · Cited by 48
Ethanol sensitization in a neurodevelopmental lesion model of Schizophrenia in rats
Conroy, S. K., Rodd, Z. A., & Chambers, R. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.017 · Cited by 48
Smith, M. J., Barch, D. M., Wolf, T., Mamah, D. T., & Csernansky, J. G. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.015 · Cited by 47
Jeanblanc, J., Balguerie, K., Coune, F., Legastelois, R., Jeanblanc, V., & Naassïla, M. (2014) · Addiction Biology · doi:10.1111/adb.12146 · Cited by 46
Brain Circuits That Link Schizophrenia to High Risk of Cigarette Smoking
Moran, L. V., Sampath, H., Kochunov, P., & Hong, L. E. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs149 · Cited by 46
Karam, E. G., Yabroudi, P., & Melhem, N. (2002) · Comprehensive Psychiatry · doi:10.1053/comp.2002.35910 · Cited by 46
Rethinking the association between smoking and schizophrenia
Gage, S. H., & Munafo, M. R. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00057-1 · Cited by 44
Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia
Brady, A. M., McCallum, S. E., Glick, S. D., & O’Donnell, P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1195-7 · Cited by 43
Strong, C., Juon, H., & Ensminger, M. E. (2016) · Substance Use & Misuse · doi:10.3109/10826084.2015.1073323 · Cited by 42
McClory, A. J., & SPEAR, L. P. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.05.006 · Cited by 41
Insular and anterior cingulate circuits in smokers with schizophrenia
Moran, L. V., Sampath, H., Stein, E. A., & Hong, L. E. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.08.033 · Cited by 41
Berg, S. A., & CHAMBERS, R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.011 · Cited by 40
Kantrowitz, J. T., Nolan, K. A., Sen, S., Simen, A. A., Lachman, H. M., & Bowers, M. B. (2009) · Psychiatric Quarterly · doi:10.1007/s11126-009-9108-4 · Cited by 39
Early adolescent nicotine exposure affects later-life cocaine reward in mice
Alajaji, M., Lazenka, M. F., Kota, D., Wise, L. E., Younis, R. M., Carroll, F. I., Levine, A., Selley, D. E., Sim-Selley, L. J., & Damaj, M. I. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.032 · Cited by 39
Boggs, D. L., Surti, T. S., Esterlis, I., Pittman, B. P., Cosgrove, K., Sewell, R. A., Ranganathan, M., & D’Souza, D. C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.047 · Cited by 39
Clozapine and substance abuse in patients with schizophrenia.
Ml, L., Dickson, R. A., Campbell, M., Oliphant, J., Gretton, H. M., & Dalby, J. T. (1998) · PubMed · Cited by 38
Machielsen, M. W. J., Veltman, D. J., van den Brink, W., & de Haan, L. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114527357 · Cited by 37
Pomfrey, R. L., Bostwick, T. A., Wetzell, B., & Riley, A. L. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.08.004 · Cited by 36
Concurrent validation of schizotaxia: a pilot study
Stone, W. S., Faraone, S. V., Seidman, L. J., Green, A. I., Wojcik, J., & Tsuang, M. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01116-7 · Cited by 35
Self-citationCheah, S.-Y., Lawford, B. R., Young, R. M., Connor, J. P., Morris, C. P., & Voisey, J. (2014) · Alcohol and Alcoholism · doi:10.1093/alcalc/agu040 · Cited by 34
Clark, J. J., Nasrallah, N. A., Hart, A. S., Collins, A. L., Bernstein, I. L., & Phillips, P. E. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037357 · Cited by 34
Smoking as a causal risk factor for schizophrenia
Gage, S. H., & Munafo, M. R. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00333-8 · Cited by 32
Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?
Arranz, B., Safont, G., Corripio, I., Ramirez, N., Dueñas, R., Pérez, V., Álvarez, E., & San, L. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1113761 · Cited by 30
Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophrenia
Berg, S. A., Czachowski, C. L., & Chambers, R. A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.12.017 · Cited by 29
Rabin, R. A., Kozak, K., Zakzanis, K. K., Remington, G. J., & George, T. P. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.010 · Cited by 27
Chambers, R. A., McClintick, J. N., Sentir, A. M., Berg, S. A., Runyan, M., Choi, K. H., & Edenberg, H. J. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12051 · Cited by 25
Chambers, R. A., Sentir, A. M., & Engleman, E. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1929-1 · Cited by 25
The effects of cannabis use on the clinical condition of schizophrenics.
Negrete, J. C., & Knapp, W. P. (1986) · PsycEXTRA Dataset · doi:10.1037/e471282004-001 · Cited by 25
Dow-Edwards, D., & Izenwasser, S. (2011) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.003 · Cited by 24
Wu, B., Chen, H., & Lee, S.-M. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31828b2575 · Cited by 24
Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings
Potvin, S., Lungu, O., Lipp, O., Lalonde, P., Zaharieva, V., Stip, É., Melun, J.-P., & Mendrek, A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.03.011 · Cited by 24
Schizophrenia and co-occurring substance use disorder: Reward, olfaction and clozapine
Mesholam‐Gately, R. I., Gibson, L. E., Seidman, L. J., & Green, A. I. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.002 · Cited by 20
Self-citationRodríguez‐Arias, M., Roger-Sánchez, C., Vilanova, I., Revert, N., Manzanedo, C., Miñarro, J., & Aguilar, M. A. (2015) · Neural Plasticity · doi:10.1155/2016/6481862 · Cited by 20
Gründel, A., Schorer, J., Strauß, B., & Baker, J. R. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00129 · Cited by 17
Brunette, M. F., O’Keefe, C. D., Zimmet, S. V., Wojcik, J., Dawson, R., Brownell, E., & Green, A. I. (2008) · Journal of Dual Diagnosis · doi:10.1080/15504260802313816 · Cited by 6
Self-citationDazed and Confused by Self-Medication
Chambers, R. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10010099 · Cited by 3
Finch (1996) · doi:10.1002/(sici)1098-1063(1996)6:5<495::aid-hipo3>3.0.co;2-i
Cited by
Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.011 · Cited by 482
Autism Spectrum Disorder and Substance Use Disorder
Kunreuther, E. (2020) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2020.03.002 · Cited by 333
Psychosocial interventions for people with both severe mental illness and substance misuse
Hunt, G. E., Siegfried, N., Morley, K., Brooke-Sumner, C., & Cleary, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088.pub4 · Cited by 105
Vermeulen, J. M., Wootton, R. E., Treur, J. L., Sallis, H. M., Jones, H. J., Zammit, S., van den Brink, W., Goodwin, G. M., de Haan, L., & Munafò, M. R. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.202 · Cited by 78
Drug use among youth: National survey data support a common liability of all drug use
DuPont, R. L., Han, B., Shea, C. L., & Madras, B. K. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.05.015 · Cited by 64
Metadata
- Authors
- Khokhar, J. Y., Dwiel, L. L., Henricks, A. M., Doucette, W. T., & Green, A. I.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 194
- Pages
- 78-85
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2605688616
- Cited by
- 281
- References
- 151
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.